Application of NanoString technologies in companion diagnostic development

References

• Veldman-Jones MH, Brant R, Rooney C, et al. Evaluating robustness and sensitivity of the NanoString technologies nCounter platform to enable multiplexed gene expression analysis of clinical samples. Cancer Res. 2015;75(13):2587–2593.
   PubMed Web of Science ®Google Scholar
• Reis PP, Waldron L, Goswami RS, et al. mRNA transcript quantification in archival samples using multiplexed, color-coded probes. BMC Biotechnol. 2011;11(1):46.
   PubMedGoogle Scholar
• Brumbaugh CD, Kim HJ, Giovacchini M, et al. NanoStriDE: normalization and differential expression analysis of NanoString nCounter data. BMC Bioinformatics. 2011;12(1):479.
   PubMedGoogle Scholar
• Kulkarni MM. Digital multiplexed gene expression analysis using the NanoString nCounter system. Curr Protoc Mol Biol. 2011; 94(1)25B–10.
   Google Scholar
• Malkov VA, Serikawa KA, Balantac N, et al. Multiplexed measurements of gene signatures in different analytes using the Nanostring nCounter assay system. BMC Res Notes. 2009;2:80.
   PubMedGoogle Scholar
• M’Boutchou MN, van Kempen LC. Analysis of the tumor microenvironment transcriptome via NanoString mRNA and miRNA expression profiling. Methods Mol Biol. 2016;1458:291–310.
   PubMedGoogle Scholar
• Redekop WK, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health. 2013;16(6):S4–9.
   PubMed Web of Science ®Google Scholar
• A Fairley J, Gilmour K, Walsh K. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue. Curr Drug Targets. 2012;13(12):1475–1487.
   PubMed Web of Science ®Google Scholar
• FDA. Companion diagnostics. 2018. [online] [cited 2018 Apr 16]. Available from: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm407297.htm.
   Google Scholar
• FDA. List of cleared or approved companion diagnostic devices (in vitro and imaging tools). 2018. [online] [cited 2018 Apr 16] Available from: https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/InVitroDiagnostics/ucm301431.htm.
   Google Scholar
• Tsang HF, Xue VW, Koh SP, et al. NanoString, a novel digital color-coded barcode technology: current and future applications in molecular diagnostics. Expert Rev Mol Diagn. 2017;17(1):95–103.
   PubMed Web of Science ®Google Scholar
• Tekletsion Y, Christensen H, Finn A. Gene detection and expression profiling of Neisseria meningitidis using NanoString nCounter platform. J Microbiol Methods. 2018;146:100–103.
   PubMed Web of Science ®Google Scholar
• Foye C, Yan I, David W, et al. Comparison of miRNA quantitation by Nanostring in serum and plasma samples. PLoS One. 2017;12(12):e0189165.
   PubMed Web of Science ®Google Scholar
• Huang B, West N, Vider J, et al. Diagnosis and typing of influenza using fluorescent barcoded probes. Sci Rep. 2017;7(1):18092.
   PubMedGoogle Scholar
• Wallden B, Storhoff J, Nieisen T, et al. Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. BMC Med Genomics. 2015;8:54.
   PubMed Web of Science ®Google Scholar
• Prosigna. See the difference with Prosigna -- breast cancer prognostic gene signature assay. 2017; [online] p.1–4. [cited 2017 Jul] Available from: http://prosigna.com/docs/Prosigna_Product_Data_Sheet_US.pdf.
   Google Scholar
• Agarwal A, Ressler D, Snyder G. The current and future state of companion diagnostics. Pharmgenomics Pers Med. 2015;8:99–110.
   PubMed Web of Science ®Google Scholar
• Cesano A, Warren S. Bringing the next generation of immuno-oncology biomarkers to the clinic. Biomedicines. 2018;6(1):14.
   PubMed Web of Science ®Google Scholar
• Lira ME, Kim TM, Huang D, et al. Multiplexed gene expression and fusion transcript analysis to detect ALK fusions in lung cancer. J Mol Diagn. 2013;15(1):51–61.
   PubMed Web of Science ®Google Scholar
• Chang KTE, Goytain A, Tucker T, et al. Development and evaluation of a pan-sarcoma fusion gene detection assay using the NanoString nCounter platform. J Mol Diagn. 2018;20(1):63–77.
   PubMed Web of Science ®Google Scholar
• Ma W, Gilligan BM, Yuan J, et al. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol. 2016;9(1):47.
   PubMedGoogle Scholar
• Ayers M, Lunceford J, Nebozhyn M, et al. IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930–2940.
   PubMed Web of Science ®Google Scholar
• Chen DS, Mellman I. Elements of cancer immunity and the cancer–immune set point. Nature. 2017;541(7637):321–330.
   PubMed Web of Science ®Google Scholar
• Observer ML NanoString and celgene join forces to develop gene-based companion diagnostics. 2014. [Online]. Available from: https://www.mlo-online.com/nanostring-and-celgene-join-forces-to-develop-gene-based-companion-diagnostics.php.
   Google Scholar
• Camicia R, Winkler HC, Hassa PO. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer. 2015;14:207.
   PubMed Web of Science ®Google Scholar
• Jinho L, Christopher PV, Gavin M, et al. 3D biology view of cancer: simultaneous detection of somatic DNA mutations and expression profiling of genes and signaling proteins from melanoma tumor FFPE samples. Advances in Genome Biology and Technology (AGBT) Conference. Diplomat Beach Resort, Hollywood Beach, Florida, USA. 2017.
   Google Scholar
• Mark M, Tushar R, Matt W, et al. Direct single-molecule RNA sequencing without cDNA conversion using Hyb & SeqTM chemistry. Advances in Genome Biology and Technology (AGBT) conference. Diplomat Beach Resort, Hollywood Beach, Florida, USA. 2017.
   Google Scholar
• Farrell D. NanoString highlights progress on product roadmap featuring multiple innovative technologies .Advances in Genome Biology and Technology (AGBT) conference. Diplomat Beach Resort, Hollywood Beach, Florida, USA. 2017.
   Google Scholar
• Fiziev P, Akdemir KC, Miller JP, et al. Systematic epigenomic analysis reveals chromatin states associated with melanoma progression. Cell Rep. 2017;19(4):875–889.
   PubMed Web of Science ®Google Scholar
• Pohjanvirta R, Niittynen M, Linden J, et al. Evaluation of various housekeeping genes for their applicability for normalization of mRNA expression in dioxin-treated rats. Chem Biol Interact. 2006;160:134–149.
   PubMed Web of Science ®Google Scholar
• Narrandes S, Xu W. Gene expression detection assay for cancer clinical use. J Cancer. 2018;9(13):2249–2265.
   PubMed Web of Science ®Google Scholar